Related references
Note: Only part of the references are listed.Ras-driven proliferation and apoptosis signaling during rat liver carcinogenesis is under genetic control
Diego F. Calvisi et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Inflammation and cancer: An ancient link with novel potentials
S. Perwez Hussain et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation
Lei Ying et al.
CANCER RESEARCH (2007)
Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα
Paraskevi Briassouli et al.
CANCER RESEARCH (2007)
iNOS-dependent DNA damage in patients with malignant fibrous histiocytoma in relation to prognosis
Yoko Hoki et al.
CANCER SCIENCE (2007)
Expression of inducible nitric oxide (NO) synthase but not prevention by its gene ablation of hepatocarcinogenesis with fibrosis caused by a choline-deficient, L-amino acid-defined diet in rats and mice
Ayumi Denda et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2007)
Reversing hepatocellular carcinoma progression by using networked biological therapies
Richard J. Epstein et al.
CLINICAL CANCER RESEARCH (2007)
Regulation of human nitric oxide synthase 2 expression by Wnt β-catenin signaling
Qiang Du et al.
CANCER RESEARCH (2006)
Regulation of iNOS by the p44/42 mitogen-activated protein kinase pathway in human melanoma
J. A. Ellerhorst et al.
ONCOGENE (2006)
Hepatocellular carcinoma as a complex polygenic disease. Interpretive analysis of recent developments on genetic predisposition
F. Feo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2006)
Naturally occurring biflavonoid, ochnaflavone, inhibits LPS-induced iNOS expression, which is mediated by ERK1/2 via NF-κB regulation, in RAW264.7 cells
SJ Suh et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2006)
Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas:: is there any correlation with angiogenesis or clinicopathologic parameters?
E Özel et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines
N Lasagna et al.
CANCER RESEARCH (2006)
Role of HSP90, CDC37, and CRM1 as modulators of P16INK4A activity in rat liver carcinogenesis and human liver cancer
RM Pascale et al.
HEPATOLOGY (2005)
Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands:: Correlations with the angiogenesis and clinical outcome
JL Zhang et al.
CLINICAL CANCER RESEARCH (2005)
Expressions of inducible nitric oxide synthase and matrix metalloproteinase-9 and their effects on angiogenesis and progression of hepatocellular carcinoma
Min-Hua Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Inducible nitric oxide synthase, nitrotyrosine and apoptosis in gastric adenocarcinomas and their correlation with a poor survival
Long-Gang Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Chemopreventive N-(4-hydroxyphenyl)retinamide (fenretinide) targets deregulated NF-κB and Mat1A genes in the early stages of rat liver carcinogenesis
MM Simile et al.
CARCINOGENESIS (2005)
Molecular mechanisms of hepatocarcinogenesis in transgenic mouse models of liver cancer
DF Calvisi et al.
TOXICOLOGIC PATHOLOGY (2005)
Cyclooxygenase-2 activation mediates the proangiogenic effect of nitric oxide in colorectal cancer
F Cianchi et al.
CLINICAL CANCER RESEARCH (2004)
The IKK/NF-κB activation pathway -: a target for prevention and treatment of cancer
FR Greten et al.
CANCER LETTERS (2004)
Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling
JS Lee et al.
HEPATOLOGY (2004)
Disregulation of E-cadherin in transgenic mouse models of liver cancer
DF Calvisi et al.
LABORATORY INVESTIGATION (2004)
Hepatitis C virus infection activates the immunologic (type II) isoform of nitric oxide synthase and thereby enhances DNA damage and mutations of cellular genes
K Machida et al.
JOURNAL OF VIROLOGY (2004)
Application of comparative functional genomics to identify best-fit mouse models to study human cancer
JS Lee et al.
NATURE GENETICS (2004)
Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-α transgenic mouse model of liver cancer
DF Calvisi et al.
JOURNAL OF HEPATOLOGY (2004)
Primary liver cancer:: Worldwide incidence and trends
FX Bosch et al.
GASTROENTEROLOGY (2004)
Enhanced chemosensitivity to irinotecan by RNA interference mediated down-regulation of the nuclear factor-κB p65 subunit
J Guo et al.
CLINICAL CANCER RESEARCH (2004)
Disruption of β-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice
DF Calvisi et al.
GASTROENTEROLOGY (2004)
Role of cyclooxygenase-2 and inducible nitric oxide synthase in pancreatic cancer
G Kong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis
RM Pascale et al.
HEPATOLOGY (2002)
Absence of inducible nitric oxide synthase modulates early reperfusion-induced NF-kappa B and AP-1 activation and enhances myocardial damage
B Zingarelli et al.
FASEB JOURNAL (2002)
Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
CK Weber et al.
GASTROENTEROLOGY (2000)
Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras
AA Deora et al.
BIOCHEMISTRY (2000)
Expression of a dominant-negative mutant of p21ras inhibits induction of nitric oxide synthase and activation of nuclear factor-κB in primary astrocytes
K Pahan et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Detection of somatic DNA alterations in azoxymethane-induced F344 rat colon tumors by random amplified polymorphic DNA analysis
C Luceri et al.
CARCINOGENESIS (2000)
Share Paper
